Aligos Therapeutics Inc. buy BiotechBee
Start price
03.03.24
/
50%
€1.06
Target price
30.04.26
€3.00
Performance (%)
-55.42%
Price
12.07.24
€0.47
Summary
This prediction is currently active. The BUY prediction by BiotechBee for Aligos Therapeutics Inc. is performing very badly with a performance of -55.42%. This prediction currently runs until 30.04.26. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Aligos Therapeutics Inc. | - | - |
iShares Core DAX® | 1.454% | 0.904% |
iShares Nasdaq 100 | -0.913% | 3.463% |
iShares Nikkei 225® | 2.355% | 3.830% |
iShares S&P 500 | 0.283% | 2.639% |
According to BiotechBee what are the pros and cons of Aligos Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Aligos Therapeutics Inc. diskutieren
Buy mit Kursziel 3,0